Status:
COMPLETED
Interactive Group Drumming (IGD) in Hospital Experience of Patients Undergoing Hematopoietic Stem Cell Transplant - A Pilot Study
Lead Sponsor:
Wake Forest University Health Sciences
Conditions:
Hematopoietic Cell Transplant
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this research is to determine if it is possible to perform group drumming as an intervention during HCT, to begin to understand how interactive group drumming during HCT treatment affec...
Detailed Description
The purpose of this research is to determine if it is possible to perform group drumming as an intervention during HCT, to begin to understand how interactive group drumming during HCT treatment affec...
Eligibility Criteria
Inclusion
- People who are at least 18 years old and are scheduled for HCT
- Individuals must be able to understand and willing to sign a written informed consent form
Exclusion
- People who are too ill to participate, i.e., while they are in contact isolation or have low platelets (less than 20,000/mcl) will not participate until their condition has improved.
- Patients receiving outpatient HCT except patients with multiple myeloma. Patients with multiple myeloma may participate in the study even though they tend to spend nights away from the hospital.
Key Trial Info
Start Date :
November 15 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 4 2019
Estimated Enrollment :
35 Patients enrolled
Trial Details
Trial ID
NCT03345433
Start Date
November 15 2017
End Date
December 4 2019
Last Update
May 14 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Wake Forest University Health Sciences
Winston-Salem, North Carolina, United States, 27157